Discounted Cash Flow
Zepp Health Corp. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.6b | $3.5m | $1.0m | 0.2% | $-0.22 |
| 2017 | $314.9m (-79.8%) | $3.8m (7.6%) | $34.8m (3261.5%) | 1.2% (431.9%) | $0.10 (145.5%) |
| 2018 | $530.2m (68.4%) | $7.3m (91.9%) | $7.3m (-79.0%) | 1.4% (14.0%) | $0.08 (-20.0%) |
| 2019 | $834.9m (57.5%) | $12.2m (67.1%) | $62.6m (755.4%) | 1.5% (6.1%) | $0.34 (325.0%) |
| 2020 | $986.0m (18.1%) | $5.2m (-57.6%) | $21.4m (-65.8%) | 0.5% (-64.1%) | $0.14 (-58.8%) |
| 2021 | $980.8m (-0.5%) | $3.2m (-38.3%) | $3.2m (-85.0%) | 0.3% (-38.0%) | $0.09 (-35.7%) |
| 2022 | $600.7m (-38.8%) | $-6.2m (-293.3%) | $-6.2m (-293.3%) | -1.0% (-415.6%) | $-0.17 (-288.9%) |
| 2023 | $351.5m (-41.5%) | $-4.4m (28.5%) | $44.0m (810.7%) | -1.3% (-22.2%) | $-0.12 (29.4%) |
| 2024 | $182.6m (-48.0%) | $-11.2m (-153.5%) | $-3.8m (-108.7%) | -6.1% (-387.9%) | $-0.29 (-141.7%) |
| 2025 | $258.9m (41.8%) | $-5.9m (47.1%) | $-3.9m (-1.6%) | -2.3% (62.7%) | $-0.16 (44.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
SEC filings report in CNY. Values above are converted to USD for comparison with the US-listed share price.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.